<div id="readability-page-1"><div><p>Fortress Value Acquisition V, the sixth blank check company by executives at Fortress Investment Group, raised $250 million by offering 25 million shares at $10. Unlike most SPACs, the company is offering shares, instead of units with warrants and/or rights attached.</p><p>Fortress Value Acquisition V is led by <strong>Chairman Andrew McKnight</strong>, who serves as a co-CEO and Managing Director at Fortress Investment Group. He is joined by <strong>co-CEOs Andrew Stroud</strong> and <strong>Micah Kaplan</strong>, who both serve as Managing Directors at Fortress Investment Group, as well as <strong>CFO John Konawalik</strong>, the CAO of Fortress Investment Group.</p><p>Management's previous SPACs include Fortress Value Acquisition IV (formerly NYSE: FVIV.U) and Fortress Value Acquisition III (formerly NYSE: FVT.U), which both liquidated in 2022, as well as Fortress Value Acquisition II, which merged with ATI Physical Therapy (formerly NYSE: ATIP) in 2021, and Fortress Value Acquisition I, which merged with MP Materials (NYSE: MP; +487% from $10 offer price) in 2020.</p><p>Fortress Value Acquisition V plans to list on the Nasdaq under the symbol FVAV. Deutsche Bank acted as sole bookrunner on the deal.</p></div></div>

FBIOP

FNCL

FBIO

<p>Fortress Value Acquisition V, a SPAC by Fortress Investment Group, has priced its IPO at $250 million, offering 25 million shares at $10 each. Unlike typical SPACs, it is offering shares without attached warrants. The SPAC is led by Andrew McKnight, Andrew Stroud, and Micah Kaplan, with John Konawalik as CFO. Previous SPACs from Fortress include Fortress Value Acquisition IV and III, both of which liquidated in 2022. Fortress Value Acquisition V plans to list on Nasdaq under the symbol FVAV, with Deutsche Bank as the sole bookrunner.</p>

RenaissanceCapital

Fortress Biotech Pref Share FBIOP 9.375 15/12/22

ISHRS Us Brokers & Sec Exchg

Financial Select Sector SPDR Fund

VG Financial

Fidelity MSCI Financials Index

Fortress Biotech

SPAC Fortress Investment Group's Fortress Value Acquisition V prices $250 million IPO